These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 15215141)

  • 1. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
    Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
    van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an
    Abd Algaffar SO; Verbon A; van de Sande WWJ; Khalid SA
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.
    Hawser SP; Norris H; Jessup CJ; Ghannoum MA
    J Clin Microbiol; 1998 May; 36(5):1450-2. PubMed ID: 9574729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE; Wiederhold NP; Klepser ME
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyl-amino)carbonyl]-2H-tetrazolium hydroxide (XTT) and minimum effective concentration assays in the determination of antifungal susceptibility of Aspergillus fumigatus to the lipopeptide class compounds.
    Hawser SP; Jessup C; Vitullo J; Ghannoum MA
    J Clin Microbiol; 2001 Jul; 39(7):2738-41. PubMed ID: 11427611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol.
    Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG
    J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance and costs of XTT, resazurin, MTS and luciferin as viability dyes in in vitro susceptibility testing of Madurella mycetomatis.
    Ma J; Eadie K; Fahal A; Verbon A; van de Sande WWJ
    Trans R Soc Trop Med Hyg; 2024 Nov; 118(11):729-735. PubMed ID: 38721683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between the standardized clinical and laboratory standards institute M38-A2 method and a 2,3-Bis(2-Methoxy-4-Nitro-5-[(Sulphenylamino)Carbonyl]-2H-tetrazolium hydroxide- based method for testing antifungal susceptibility of dermatophytes.
    Shehata AS; Mukherjee PK; Ghannoum MA
    J Clin Microbiol; 2008 Nov; 46(11):3668-71. PubMed ID: 18832129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B but not itraconazole is able to prevent grain formation in experimental Madurella mycetomatis mycetoma in mice.
    van de Sande WW; van Vianen W; ten Kate M; Fahal A; Bakker-Woudenberg I
    Br J Dermatol; 2015 Dec; 173(6):1561-2. PubMed ID: 26150103
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
    van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A
    Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of caspofungin combined with sulfamethoxazole against clinical isolates of Aspergillus spp.
    Yekutiel A; Shalit I; Shadkchan Y; Osherov N
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3279-83. PubMed ID: 15328085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
    Kloezen W; Meis JF; Curfs-Breuker I; Fahal AH; van de Sande WW
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6054-6. PubMed ID: 22964246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
    Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
    Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antifungal drug susceptibilities of Aspergillus species by a fluorescence-based microplate assay.
    Balajee SA; Imhof A; Gribskov JL; Marr KA
    J Antimicrob Chemother; 2005 Jan; 55(1):102-5. PubMed ID: 15546970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH on the in vitro activities of amphotericin B, itraconazole, and flucytosine against Aspergillus isolates.
    Te Dorsthorst DT; Mouton JW; van den Beukel CJ; van der Lee HA; Meis JF; Verweij PE
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3147-50. PubMed ID: 15273136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J; Peláez T; Alcalá L; Bouza E
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
    Tellier R; Krajden M; Grigoriew GA; Campbell I
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1619-25. PubMed ID: 1416843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.